Derek Cocker, Taonga Mwapasa, Roman Grabic, Kateřina Grabicová, Andrea Vojs Staňová, Kondwani Chidziwisano, Adam P Roberts, Tracy Morse, Nicholas A Feasey, Andrew C Singer
{"title":"Environmental hazards from pollution of antibiotics and resistance-driving chemicals in an urban river network from Malawi.","authors":"Derek Cocker, Taonga Mwapasa, Roman Grabic, Kateřina Grabicová, Andrea Vojs Staňová, Kondwani Chidziwisano, Adam P Roberts, Tracy Morse, Nicholas A Feasey, Andrew C Singer","doi":"10.1038/s44259-025-00149-5","DOIUrl":"10.1038/s44259-025-00149-5","url":null,"abstract":"<p><p>African communities have a high prevalence of antimicrobial-resistant bacterial carriage, alongside high levels of antibiotic usage and environmental pollution. Limited access to water, sanitation and hygiene infrastructure and wastewater treatment facilities enables the dissemination of resistant bacteria, antimicrobials and antibiotic resistance-driving chemicals (ARDCs) into local rivers. Few data exist quantifying the chemical drivers of antimicrobial resistance (AMR) in urban aquatic environments from African settings. In this longitudinal surveillance study, we investigated an urban river network in Blantyre, Malawi over a continuous 12-month period, identifying a broad-range of chemical pollutants, including antibiotics, common pharmaceuticals, agricultural and industrial chemicals and heavy metals. Antimicrobial concentrations were found at levels selective for AMR and ARDCs exhibited seasonal variations, indicating that deficient sanitation infrastructure and anthropogenic factors result in high antibiotic and ARDC levels entering the river systems, which serve as an important ecological niche for the acquisition, maintenance and transmission of AMR.</p>","PeriodicalId":520007,"journal":{"name":"npj antimicrobials and resistance","volume":"3 1","pages":"85"},"PeriodicalIF":0.0,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12511589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Corinne J Arnold, Laetitia Chartrain, David M Lawson, James K M Brown
{"title":"Resistance of ERG24 sterol C-14 reductase to heterocyclic amine antifungals.","authors":"Corinne J Arnold, Laetitia Chartrain, David M Lawson, James K M Brown","doi":"10.1038/s44259-025-00155-7","DOIUrl":"10.1038/s44259-025-00155-7","url":null,"abstract":"<p><p>There is an urgent need for a wider range of antifungals in medicine and agriculture and for their dual use in both contexts to be minimised. As new modes of action may incur unforeseen side-effects, existing groups of antifungals which have had limited use may be attractive options for development. Here, we report mutations in ERG24 sterol C-14 reductase which cause resistance of wheat powdery mildew to heterocyclic amine fungicides with a phenylpropyl chain, and confirm their effect by single-base editing in yeast. The resistance mutations have at most small effects on mitotic fitness measured by yeast growth parameters. Predictive protein modelling indicates that phenylpropylamines likely obstruct the sterol substrate's access to the catalytic site, and thus act as competitive inhibitors, but do not bind directly to the catalytic residues. This information may support structure-guided development of new antifungals targetting ERG24 as alternatives to the widely-used ERG11 inhibitors.</p>","PeriodicalId":520007,"journal":{"name":"npj antimicrobials and resistance","volume":"3 1","pages":"83"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12489058/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jason L Brown, William Johnston, Mark C Butcher, Mia Burleigh, Gordon Ramage
{"title":"The butterfly effect: collateral damage and impacts of antimicrobial strategies on the oral microbiome.","authors":"Jason L Brown, William Johnston, Mark C Butcher, Mia Burleigh, Gordon Ramage","doi":"10.1038/s44259-025-00156-6","DOIUrl":"10.1038/s44259-025-00156-6","url":null,"abstract":"<p><p>The oral cavity is a complex environment hosting diverse microbial biofilms on different surfaces, all immersed in saliva that enables recolonisation and spread. These microbial populations fluctuate with diet, hygiene, antimicrobials, and disease. While biofilm control measures aim to protect health, they may cause unintended effects, including antimicrobial resistance (AMR). Persistent resistant microbes reshape oral and systemic niches through ecological disruption and genetic adaptation, which may negatively impact human health.</p>","PeriodicalId":520007,"journal":{"name":"npj antimicrobials and resistance","volume":"3 1","pages":"84"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12489097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ayella Maile-Moskowitz, Connor L Brown, Monjura Afrin Rumi, Nazifa Ahmed Moumi, Haniyyah Majeed, Carla V Finkielstein, Alessandro Ceci, Raul Gonzalez, Kang Xia, Lauren McDaniel, Anthony Baffoe-Bonnie, Jayasimha Rao, Liqing Zhang, Amy Pruden, Peter J Vikesland
{"title":"Relating antimicrobial use to wastewater resistance gene patterns via metagenomic analysis of two neighboring treatment plants circa the COVID-19 pandemic.","authors":"Ayella Maile-Moskowitz, Connor L Brown, Monjura Afrin Rumi, Nazifa Ahmed Moumi, Haniyyah Majeed, Carla V Finkielstein, Alessandro Ceci, Raul Gonzalez, Kang Xia, Lauren McDaniel, Anthony Baffoe-Bonnie, Jayasimha Rao, Liqing Zhang, Amy Pruden, Peter J Vikesland","doi":"10.1038/s44259-025-00153-9","DOIUrl":"10.1038/s44259-025-00153-9","url":null,"abstract":"<p><p>Minimizing antimicrobial use is a recommended strategy to reduce the evolution and spread of antibiotic resistance; however, efficacy is elusive to measure. Wastewater-based surveillance provides a promising means to relate trends in microbial community antibiotic resistance profiles as a function of interventions and other factors. We examined influent sewage metagenomes for two neighboring wastewater treatment plants (WWTPs) serving a university and a nearby community. We compared antibiotic resistance gene (ARG) profiles as a function of diagnoses of COVID-19 and other illnesses, antibiotic use, antibiotic/antimicrobial and disinfectant/quaternary ammonium compound concentrations, and COVID-19-related behavioral shifts. Diversity and abundances of ARGs unique to the corresponding sewage were consistently higher for the community WWTP, but converged in 2022 when antibiotic prescriptions surged in the university zip code. Decreases in ARG diversity/abundance were not apparent during periods of decreased antibiotic usage, indicating that extended times may be required for wastewater ARG signals to attenuate following interventions.</p>","PeriodicalId":520007,"journal":{"name":"npj antimicrobials and resistance","volume":"3 1","pages":"82"},"PeriodicalIF":0.0,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12484780/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145202661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Monika Subanovic, Dean Frawley, Ciara Tierney, Trinidad Velasco-Torrijos, Fiona Walsh
{"title":"Proteomic and metabolomic responses of priority bacterial pathogens to subinhibitory concentration of antibiotics.","authors":"Monika Subanovic, Dean Frawley, Ciara Tierney, Trinidad Velasco-Torrijos, Fiona Walsh","doi":"10.1038/s44259-025-00147-7","DOIUrl":"10.1038/s44259-025-00147-7","url":null,"abstract":"<p><p>This study employed a comprehensive proteomic and metabolomic analysis to characterize adaptive cellular mechanisms of priority pathogens-Escherichia coli, Klebsiella pneumoniae, Enterococcus faecium, and Staphylococcus aureus-under sub-inhibitory concentrations of antibiotics. Despite significant metabolomic perturbations, some pathogens had minimal or no significant changes in their proteome. Notably, trimethylamine metabolism was consistently altered across all species, suggesting its role in survival under antibiotic stress. Shared adaptive responses to chloramphenicol in S. aureus and E. faecium are related to translation, oxidative stress management, protein folding and stability, biofilm formation capacity, glycine metabolism and osmoprotection. Alterations in quaternary amines and trimethylamine metabolism suggest alternative nitrogen and carbon utilization pathways in response to antibiotic stress. In S. aureus, vancomycin suppressed metabolism, including D-alanine metabolism, and global regulators LytR, CodY and CcpA. These findings offer insights into early antimicrobial resistance mechanisms and highlight critical proteins and metabolites linked to antibiotic tolerance.</p>","PeriodicalId":520007,"journal":{"name":"npj antimicrobials and resistance","volume":"3 1","pages":"80"},"PeriodicalIF":0.0,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12441150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145077152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Uli Klümper, Peiju Fang, Bing Li, Yu Xia, Dominic Frigon, Kerry A Hamilton, Hunter Quon, Thomas U Berendonk, Magali de la Cruz Barron
{"title":"Towards the integration of antibiotic resistance gene mobility into environmental surveillance and risk assessment.","authors":"Uli Klümper, Peiju Fang, Bing Li, Yu Xia, Dominic Frigon, Kerry A Hamilton, Hunter Quon, Thomas U Berendonk, Magali de la Cruz Barron","doi":"10.1038/s44259-025-00154-8","DOIUrl":"10.1038/s44259-025-00154-8","url":null,"abstract":"<p><p>Antibiotic resistance gene (ARG) mobility plays a crucial role in the spread of antimicrobial resistance across One Health settings. Current environmental surveillance often overlooks the significance of ARG mobility, limiting risk assessment accuracy. This perspective highlights that with recent methodological advances in detecting ARG mobility, relevant databases, and improved quantitative microbial risk assessment frameworks, the time to integrate ARG mobility into environmental antimicrobial resistance (AMR) surveillance and risk assessment is now.</p>","PeriodicalId":520007,"journal":{"name":"npj antimicrobials and resistance","volume":"3 1","pages":"81"},"PeriodicalIF":0.0,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12441123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145077194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cian Smyth, Robert J Leigh, Thi Thuy Do, Fiona Walsh
{"title":"Communities of plasmids as strategies for antimicrobial resistance gene survival in wastewater treatment plant effluent.","authors":"Cian Smyth, Robert J Leigh, Thi Thuy Do, Fiona Walsh","doi":"10.1038/s44259-025-00151-x","DOIUrl":"10.1038/s44259-025-00151-x","url":null,"abstract":"<p><p>Plasmids facilitate antimicrobial resistance (AMR) gene spread via horizontal gene transfer, yet the mobility of genes in wastewater treatment plant (WWTP) resistomes remains unclear. We sequenced 173 circularised plasmids transferred from WWTP effluent into Escherichia coli and characterised their genetic content. Multiple multidrug-resistant plasmids were identified, with a significant number of mega-plasmids (>100 kb). Almost all plasmids detected existed with other plasmids i.e. as communities rather than lone entities. These plasmid communities enabled non-AMR plasmids to survive antimicrobial selection by co-existing with resistant partners. Our data demonstrates the highly variable nature of plasmids in addition to their capacity to carry mobile elements and genes within these highly variable regions. The impact of these variations on plasmid ecology, persistence, and transfer requires further investigation. Plasmid communities warrant exploration across biomes, as many non-resistant plasmids escape elimination by co-existing with AMR plasmids in the same bacterial host, representing a previously unrecognised survival strategy.</p>","PeriodicalId":520007,"journal":{"name":"npj antimicrobials and resistance","volume":"3 1","pages":"78"},"PeriodicalIF":0.0,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12420782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145031622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carmen Li, Serkan Sayin, Ethan Hau Chian Chang, Amir Mitchell
{"title":"Predicting drug inactivation by changes in bacterial growth dynamics.","authors":"Carmen Li, Serkan Sayin, Ethan Hau Chian Chang, Amir Mitchell","doi":"10.1038/s44259-025-00152-w","DOIUrl":"10.1038/s44259-025-00152-w","url":null,"abstract":"<p><p>Studying how antibacterials operate at subinhibitory concentrations reveals how they impede normal growth. While previous works demonstrated drugs can impact multiple aspects of growth, such as prolonging the doubling time or reducing the maximal bacterial load, a systematic understanding of this phenomenon is lacking. It remains unknown if common principles dictate how drugs interfere with growth. We monitored growth curves across thirty-eight drugs, spanning multiple mechanisms of action in Escherichia coli to deconvolve their impact on the lag, growth rate, and carrying capacity and developed a mathematical framework to quantitatively compare their effects. We discovered that drugs induced considerably different inhibition phenotypes, which were independent from the drug's target. Functional assays of drug inactivation revealed that drug inactivation is a key shared factor underlying a lag-associated phenotype. Our work reveals that likely drug inactivation can be directly inferred from growth dynamics which is instrumental for rapidly identifying drug-inactivating bacteria.</p>","PeriodicalId":520007,"journal":{"name":"npj antimicrobials and resistance","volume":"3 1","pages":"79"},"PeriodicalIF":0.0,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12420825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145031674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Darren Shu Jeng Ting, Thet Tun Aung, Venkatesh Mayandi, Mercy Halleluyah Periayah, Eunice Tze Leng Goh, Mugil Muthu, Veluchamy Amutha Barathi, Jodhbir S Mehta, Donald Tiang Hwee Tan, Rajamani Lakshminarayanan
{"title":"Biosynthetic ε-poly-L-lysine for the treatment of extensively- and pan-drug-resistant Pseudomonas aeruginosa.","authors":"Darren Shu Jeng Ting, Thet Tun Aung, Venkatesh Mayandi, Mercy Halleluyah Periayah, Eunice Tze Leng Goh, Mugil Muthu, Veluchamy Amutha Barathi, Jodhbir S Mehta, Donald Tiang Hwee Tan, Rajamani Lakshminarayanan","doi":"10.1038/s44259-025-00142-y","DOIUrl":"10.1038/s44259-025-00142-y","url":null,"abstract":"<p><p>Pseudomonas aeruginosa (PA) represents a major cause of antimicrobial resistance-related morbidity and mortality. The recent emergence of highly fatal infections, caused by carbapenem-resistant PA, has called for novel antimicrobial therapies and strategies. In this study, we highlight the therapeutic potential of ε-poly-L-lysine (εPL), an antimicrobial polymer for treating extensively-and pan-drug-resistant-PA. εPL displayed potent antimicrobial activity against all eight drug-resistant PA, including carbapenem- and polymyxin-resistant PA. It exhibited a low risk of AMR evolution, with no evidence of cross-resistance with polymyxin B (a last-line treatment for drug-resistant Gram-negative bacteria). We further demonstrated promising in vivo efficacy and safety of εPL against PA in a pre-clinical PA keratitis model, with comparable effects to topical levofloxacin (a gold standard treatment of infectious keratitis) in terms of clinical scoring, corneal health/thickness, and bacterial bioburden. In view of its broad-spectrum antimicrobial activity, low risk of AMR evolution and cross-resistance with existing last-line antibiotics, and general acceptance of safety when orally administered, εPL serves as a promising novel antimicrobial agent for further clinical development and translation to tackle antimicrobial resistance.</p>","PeriodicalId":520007,"journal":{"name":"npj antimicrobials and resistance","volume":"3 1","pages":"77"},"PeriodicalIF":0.0,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12420815/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145031649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xisheng Xiong, Junjian Qian, Lang Wang, Jiawei Liu, Lulu Zhang, Kai Diao, Tao Tang, Xianliang Zhang, Xuri Wu, Yijun Chen
{"title":"Pharmacokinetic and pharmacodynamic studies of injectable nocathiacin as a novel antibacterial agent.","authors":"Xisheng Xiong, Junjian Qian, Lang Wang, Jiawei Liu, Lulu Zhang, Kai Diao, Tao Tang, Xianliang Zhang, Xuri Wu, Yijun Chen","doi":"10.1038/s44259-025-00148-6","DOIUrl":"10.1038/s44259-025-00148-6","url":null,"abstract":"<p><p>The extreme hydrophobicity of nocathiacin, a potent thiopeptide antibiotic against multidrug-resistant (MDR) Gram-positive pathogens, has limited its clinical development. This study formulated an injectable lyophilized nocathiacin with enhanced solubility (12.59 mg/mL). In vitro testing against 1050 clinical isolates demonstrated exceptional potency (MIC<sub>50</sub>: 0.0078-0.0156 mg/L; 64-128-fold lower than vancomycin/linezolid) and bactericidal activity (MBC<sub>50</sub> = 4-16 × MIC). Murine systemic and localized infection models showed superior efficacy (ED<sub>50</sub>: 0.64-1.96 mg/kg; ~3 log (CFU/g) reduction in lung/thigh at 2/8 mg/kg). PK/PD analysis in immunocompromised mice identified AUC<sub>0-24</sub>/MIC and %T > MIC as primary efficacy drivers (R<sup>2</sup> ≥ 0.97), indicating time-dependent killing. Favorable PK in rats/monkeys included moderate half-lives (4.7-5.5 h), biliary-dominated excretion (26.01% parent drug), minimal renal clearance (<0.10%), and no CYP inhibition/induction or significant transporter interactions. These results support injectable nocathiacin as a promising clinical candidate for MDR Gram-positive infections.</p>","PeriodicalId":520007,"journal":{"name":"npj antimicrobials and resistance","volume":"3 1","pages":"76"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12402090/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}